Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Gains from Investment Securities (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Gains from Investment Securities for 4 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 59614.87% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, up 1261.16% year-over-year, with the annual reading at $66666.0 for FY2025, 590.91% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $3.6 million at bioAffinity Technologies, up from $2113.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.6 million in Q4 2025, with the low at $2113.0 in Q3 2025.
  • Average Gains from Investment Securities over 4 years is $479409.4, with a median of $88665.0 recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 59614.87% in 2025, while the deepest fall reached 97.68% in 2025.
  • Over 4 years, Gains from Investment Securities stood at $26692.0 in 2022, then crashed by 52.94% to $12560.0 in 2023, then plummeted by 52.55% to $5960.0 in 2024, then soared by 59614.87% to $3.6 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $3.6 million, $2113.0, and $92975.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.